Functional Characterization of human stem cell-derived cardiomyocytes

Current Protocols in Pharmacology

Volumn , Issue SUPPL.64, 2014, Pages

  Kirsch, Glenn E ^a   Obejero Paz, Carlos A ^a   Bruening Wright, Andrew ^a  

^a ChanTest Corporation ^*  (United States)

Author keywords

Electrophysiology; Impedance; Stem cell derived cardiomyocytes

Indexed keywords

CALCIUM CHANNEL L TYPE; POTASSIUM; SODIUM; CALCIUM CHANNEL; ION CHANNEL;

ARTICLE; CALCIUM CURRENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMAGING SYSTEM; IMPEDANCE; PERFORATED PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; RISK ASSESSMENT; SODIUM CURRENT; STEM CELL; STEM CELL DERIVED CARDIOMYOCYTE; VOLTAGE CLAMP TECHNIQUE; WHOLE CELL PATCH CLAMP; ACTION POTENTIAL; CARDIAC MUSCLE CELL; DRUG EFFECTS; ELECTROPHYSIOLOGY; HEART CONTRACTION; PATCH CLAMP TECHNIQUE; PHYSIOLOGY;

ACTION POTENTIALS; CALCIUM CHANNELS; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; ION CHANNELS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; STEM CELLS;

EID: 84940250126     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph1112s64     Document Type: Article

References (25)

1. Amos, G.J., Wettwer, E., Metzger, F., Li, Q., Himmel, H.M., and Ravens, U. 1996. Differences between outward currents of human atrial and subepicardial ventricular myocytes. J. Physiol. 491:31-50.
2. Bers, D.M. 2002. Cardiac excitation-contraction coupling. Nature 415:198-205.
3. Braam, S.R. and Mummery, C.L. 2010. Human stem cell models for predictive cardiac safety pharmacology. Stem Cell Res. 4:155-156.
4. Cranefield, P.F. and Hoffmann, B.F. 1958. Electrophysiology of single cardiac cells. Physiol. Rev. 38:41-76.
5. Doherty, K.R., Wappel, R.L., Talbert, D.R., Trusk, P.B.,Moran, D.M., Kramer, J.W., Brown, A.M., Shell, S.A., and Bacus, S. 2013. Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol. Appl. Pharmacol. 272:245-255.
6. Furukawa, T., Koumi, S., Sakakibara, Y., Singer, D.H., Jia, H., Arentzen, C.E., Backer, C.L., and Wasserstrom, J.A. 1995. An analysis of lidocaine block of sodium current in isolated human atrial and ventricular myocytes. J. Mol. Cell Cardiol. 27:831-846.
7. Gintant, G.A., Limberis, J.T., McDermott, J.S., Wegner, C.D., and Cox, B.F. 2001. The canine Purkinje fiber: An in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. J. Cardiovasc. Pharmacol. 37:607-618.
8. Irvine, L.A., Jafri, M.S., and Winslow, R.L. 1999. Cardiac sodium channel Markov model with temperature dependence and recovery from inactivation. Biophys. J. 76:1868-1885.
9. Jonsson, M.K., Wang, Q.D., and Becker, B. 2011. Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes. Assay Drug Dev. Technol. 9:589-599.
10. Lu, H.R., Marïen, R., Saels, A., and De Clerck, F. 2001. Species plays an important role in druginduced prolongation of action potential duration and early after depolarizations in isolated Purkinje fibers. J. Cardiovasc. Electrophysiol. 12:93-102.
11. Ma, J., Guo, L., Fiene, S.J., Anson, B.D., Thomson. J.A., Kamp, T.J., Kolaja, K.L., Swanson, B.J., and January C.T. 2011. High purity humaninduced pluripotent stem cell-derived cardiomyocytes: Electrophysiological properties of action potentials and ionic currents. Am. J. Physiol. Heart. Circ. Physiol. 301:H2006-H2017.
12. Magyar, J., Iost, N., K̈ortv́ely, A., B́anýasz, T., Viŕag, L., Szigligeti, P., Varŕo, A., Opincariu, M., Sźecsi, J., Papp, J.G., and Ńańasi, P.P. 2000. Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes. Pflugers Arch. 441: 144-149.
13. Näbauer, M., Beuckelmann, D.J., Uberfuhr, P., and Steinbeck, G. 1996. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 93:168-177.
14. Nguemo, F., Šaríc, T., Pfannkuche, K., Watzele, M., Reppel, M., and Hescheler, J. 2012. In vitro model for assessing arrhythmogenic properties of drugs based on high-resolution impedance measurements. Cell. Physiol. Biochem. 29:819-832.
15. Pelzmann, B., Schaffer, P., Bernhart, E., Lang, P., M̈achler, H., Rigler, B., and Koidl, B. 1998. Ltype calcium current in human ventricular myocytes at a physiological temperature from children with tetralogy of Fallot. Cardiovasc. Res. 38:424-432.
16. Peng, S., Lacerda,A.E., Kirsch,G.E., Brown, A.M., and Bruening-Wright, A. 2010. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. J. Pharmacol. Toxicol. Methods 61:277-286.
17. Peters, M.F., Scott, C.W., Ochalski, R., and Dragan, Y.P. 2012. Evaluation of cellular impedance measures of cardiomyocyte cultures for drug screening applications. Assay Drug Dev. Technol. 10:525-532.
18. Phelan, M.C. 2007. Basic techniques in mammalian cell tissue culture. Curr. Protoc. Cell Biol. 36:1.1.1-1.1.18.
19. Radicke, S., Vaquero, M., Caballero, R., Gómez, R., Ńũnez, L., Tamargo, J., Ravens, U., Wettwer, E., and Delṕon, E. 2008. Effects ofMiRP1 and DPP6 ß-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels. Br. J. Pharmacol. 154:774-786.
20. Sakakibara, Y., Wasserstrom, J.A., Furukawa, T., Jia, H., Arentzen, C.E., Hartz, R.S., and Singer, D.H. 1992. Characterization of the sodium current in single human atrial myocytes. Circ. Res. 71:535-546.
21. Sakakibara, Y., Furukawa, T., Singer, D.H., Jia, H., Backer, C.L., Arentzen, C.E., and Wasserstrom, J.A. 1993. Sodium current in isolated human ventricular myocytes. Am. J. Physiol. 265:H1301-1309.
22. Schram, G., Pourrier, M., Melnyk, P., and Nattel, S. 2002. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ. Res. 90:939-950.
23. Wang, Z., Fermini, B., and Nattel, S. 1993. Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents. Circ. Res. 73:1061-1076.
24. Wang, Z., Fermini, B., and Nattel, S. 1995. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J. Pharmacol. Exp. Ther. 272:184-196.
25. Yamashita, T., Nakajima, T., Hamada, E., Hazama, H., Omata M., and Kurachi, Y. 1995. Flecainide inhibits the transient outward current in atrial myocytes isolated from the rabbit heart. J. Pharmacol. Exp. Ther. 274:315-321.